Lara Zakaria, PharmD, MS, CNS, FMCP, illustrates the breadth of health technology going in and out of community pharmacy practice.
|Articles|April 7, 2014
VIDEO: Capitalizing on the nutrition niche
Partly fueled by television and the internet, the demand for nutritional products and supplements is growing. Jennifer Hughes, PharmD, Greenwood Compounding Pharmacy, says pharmacies should be looking to this segment to increase profits.
Advertisement
Partly fueled by television and the Internet, the demand for nutritional products and supplements is growing. Jennifer Hughes, PharmD, Greenwood Compounding Pharmacy, says pharmacies should be looking to this segment to increase profits.
Advertisement
Related to this article
Therapy is aimed at decreasing pathogenic IgA production and immune complex formation as well as managing the effects of existing nephron loss.
Harini Bupathi, Esq, joins to discuss the impacts of PBM network terminations and how pharmacies can recover financially.
Pharmacists expand access with no-appointment care but face state laws limiting test-to-treat for COVID-19 and flu, fueling calls for advocacy.
AJ Barbarito, Esq, provides nuance to the evolving pharmacy reimbursement landscape and how PBMs and pharmacies alike are adapting as they approach 2027.
Nicole Pezzino, PharmD, BCACP, BC-ADM, CDCES, details how pharmacies can utilize the booming GLP-1 medication class for greater revenue opportunities.
Matt Martin, PharmD, BCSCP, explores current developments in the peptide space and what pharmacists need to know amid FDA decision-making processes.
This new, nonprescription therapy expands eye relief options for patients in need of apraclonidine eye drop formulations.
Advertisement
Advertisement
Trending on Drug Topics
1
PBM Underpayment Persists as Cost-Plus Brings New Strain | NCPA 2026
2
PBM Network Terminations Bring Risks Beyond Lost Contracts | NCPA 2026
3
Trutakna Reduces Proteinuria in Adults With Primary IgAN
4
Pharmacists Step Up on Test-To-Treat This American Pharmacist Month
5